Medistim ASA
OSE:MEDI
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Wall Street
Price Targets
MEDI Price Targets Summary
Medistim ASA
According to Wall Street analysts, the average 1-year price target for
MEDI
is 265.2 NOK
with a low forecast of 202 NOK and a high forecast of 336 NOK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MEDI's stock price target?
Price Target
265.2
NOK
According to Wall Street analysts, the average 1-year price target for
MEDI
is 265.2 NOK
with a low forecast of 202 NOK and a high forecast of 336 NOK.
What is Medistim ASA's Revenue forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Medistim ASA's revenue is
10%.
The projected
CAGR
for the next 3 years is
11%.
What is Medistim ASA's Operating Income forecast?
Projected CAGR
16%
For the last 13 years the
compound annual growth rate for
Medistim ASA's operating income is
14%.
The projected
CAGR
for the next 3 years is
16%.
What is Medistim ASA's Net Income forecast?
Projected CAGR
14%
For the last 13 years the
compound annual growth rate for
Medistim ASA's net income is
16%.
The projected
CAGR
for the next 3 years is
14%.
